Evaluation of Ambilhar in treatment of Schistosoma mansoni in 80 Sudanese children.
D000293:Adolescent; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D005243:Feces; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D012547:Schistosoma / Q000302:isolation & purification; D012552:Schistosomiasis / Q000188:drug therapy*; D013397:Sudan; D014839:Vomiting / Q000139:chemically induced
D000871:Anthelmintics; D001798:Blood Proteins; D007093:Imidazoles